Analysts See $0.67 EPS for Nu Skin Enterprises, Inc. (NUS)

April 19, 2018 - By wolcottdaily

Nu Skin Enterprises, Inc. (NYSE:NUS) LogoInvestors sentiment increased to 1.16 in 2017 Q4. Its up 0.09, from 1.07 in 2017Q3. It improved, as 19 investors sold Nu Skin Enterprises, Inc. shares while 75 reduced holdings. 42 funds opened positions while 67 raised stakes. 37.52 million shares or 2.40% less from 38.44 million shares in 2017Q3 were reported.
Texas Yale Cap Corporation has invested 0.02% in Nu Skin Enterprises, Inc. (NYSE:NUS). Amer Century Companies reported 124,416 shares. Thrivent Fincl For Lutherans accumulated 10,748 shares or 0% of the stock. State Of Wisconsin Invest Board holds 10,637 shares or 0% of its portfolio. Alpha Windward Ltd holds 339 shares or 0.01% of its portfolio. Amundi Pioneer Asset Mgmt Incorporated stated it has 2,810 shares or 0% of all its holdings. Arizona State Retirement System reported 35,622 shares. State Treasurer State Of Michigan, Michigan-based fund reported 17,800 shares. State Common Retirement Fund holds 0.02% of its portfolio in Nu Skin Enterprises, Inc. (NYSE:NUS) for 198,987 shares. Winslow Evans & Crocker Inc accumulated 388 shares. Deutsche Bankshares Ag holds 0% of its portfolio in Nu Skin Enterprises, Inc. (NYSE:NUS) for 77,937 shares. Old Mutual Global Investors (Uk) Limited holds 821,316 shares. 35 were reported by Glenmede Na. 25,571 are held by Jennison Associate Limited Liability. Cubist Systematic Strategies, Connecticut-based fund reported 27,674 shares.

Since January 19, 2018, it had 0 insider purchases, and 8 insider sales for $116.91 million activity. On Friday, March 2 the insider DORNY D MATTHEW sold $218,070. 15,000 shares valued at $1.08M were sold by Thomas Pisano R. on Wednesday, March 7. Lawrence Mark H had sold 724 shares worth $52,751. Another trade for 1.54 million shares valued at $107.49M was sold by Ping An ZQ China Growth Opportunity Ltd.

Analysts expect Nu Skin Enterprises, Inc. (NYSE:NUS) to report $0.67 EPS on April, 26 after the close.They anticipate $0.16 EPS change or 31.37 % from last quarter’s $0.51 EPS. NUS’s profit would be $36.37M giving it 26.50 P/E if the $0.67 EPS is correct. After having $1.20 EPS previously, Nu Skin Enterprises, Inc.’s analysts see -44.17 % EPS growth. The stock decreased 0.95% or $0.68 during the last trading session, reaching $71.01. About 223,019 shares traded. Nu Skin Enterprises, Inc. (NYSE:NUS) has risen 33.34% since April 19, 2017 and is uptrending. It has outperformed by 21.79% the S&P500.

Nu Skin Enterprises, Inc. (NYSE:NUS) Ratings Coverage

Among 3 analysts covering Nu Skin (NYSE:NUS), 1 have Buy rating, 1 Sell and 1 Hold. Therefore 33% are positive. Nu Skin had 4 analyst reports since January 23, 2018 according to SRatingsIntel. Deutsche Bank maintained the shares of NUS in report on Friday, February 16 with “Buy” rating. The firm has “Hold” rating by Deutsche Bank given on Friday, April 13. Stifel Nicolaus maintained Nu Skin Enterprises, Inc. (NYSE:NUS) rating on Thursday, February 15. Stifel Nicolaus has “Sell” rating and $57.0 target.

Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. The company has market cap of $3.86 billion. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC Transformation anti-aging skin care systems; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products. It has a 30.09 P/E ratio. The firm also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products.

Nu Skin Enterprises, Inc. (NYSE:NUS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.